BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3605398)

  • 1. Platelet membrane fluidity in Alzheimer's disease and major depression.
    Zubenko GS; Cohen BM; Reynolds CF; Boller F; Malinakova I; Keefe N
    Am J Psychiatry; 1987 Jul; 144(7):860-8. PubMed ID: 3605398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane abnormality in Alzheimer's disease.
    Zubenko GS; Cohen BM; Boller F; Malinakova I; Keefe N; Chojnacki B
    Ann Neurol; 1987 Aug; 22(2):237-44. PubMed ID: 3662454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
    Piletz JE; Sarasua M; Whitehouse P; Chotani M
    Neurobiol Aging; 1991; 12(5):401-6. PubMed ID: 1770973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of internal membranes in platelets from patients with Alzheimer's disease.
    Zubenko GS; Malinakova I; Chojnacki B
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):407-18. PubMed ID: 3598604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family study of platelet membrane fluidity in Alzheimer's disease.
    Zubenko GS; Wusylko M; Cohen BM; Boller F; Teply I
    Science; 1987 Oct; 238(4826):539-42. PubMed ID: 3659926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet membrane fluidity and treatment response in cognitively-impaired, depressed elderly: initial results.
    Zubenko GS; Reynolds CF; Perel JM; Decker C; Malinakova I
    Psychopharmacology (Berl); 1988; 94(3):347-9. PubMed ID: 3128810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between membrane fluidity and adrenoceptor binding in depression.
    Piletz JE; Sarasua M; Chotani M; Saran A; Halaris A
    Psychiatry Res; 1991 Jul; 38(1):1-12. PubMed ID: 1682966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet membrane fluidity identifies a clinical subtype of Alzheimer's disease.
    Zubenko GS; Cohen BM; Reynolds CF; Boller F; Teply I; Chojnacki B
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):683-99. PubMed ID: 3438464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial risk of dementia associated with a biologic subtype of Alzheimer's disease.
    Zubenko GS; Huff FJ; Beyer J; Auerbach J; Teply I
    Arch Gen Psychiatry; 1988 Oct; 45(10):889-93. PubMed ID: 3421803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature dependence of the molecular dynamics of platelet membranes in Alzheimer's disease.
    Zubenko GS; Malinakova I; Cohen BM
    Biol Psychiatry; 1987 Aug; 22(8):987-94. PubMed ID: 3607139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia.
    Kálmán J; Dey I; Ilona SV; Matkovics B; Brown D; Janka Z; Farkas T; Joó F
    Biol Psychiatry; 1994 Feb; 35(3):190-4. PubMed ID: 8173019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet membrane fluidity individuals at risk for Alzheimer's disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy.
    Zubenko GS; Kopp U; Seto T; Firestone LL
    Psychopharmacology (Berl); 1999 Jul; 145(2):175-80. PubMed ID: 10463318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of increased platelet membrane fluidity in mental disorders of late-life.
    Zubenko GS
    Ups J Med Sci Suppl; 1990; 48():225-44. PubMed ID: 2077697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet membrane properties in Alzheimer and multi-infarct dementias.
    Hicks N; Brammer MJ; Hymas N; Levy R
    Alzheimer Dis Assoc Disord; 1987; 1(2):90-7. PubMed ID: 3453744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.
    Zubenko GS; Teply I; Winwood E; Huff FJ; Moossy J; Sunderland T; Martinez AJ
    Am J Psychiatry; 1996 Mar; 153(3):420-3. PubMed ID: 8610834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function and platelet membrane fluidity in Alzheimer's disease.
    Zubenko GS; Huff FJ; Becker J; Beyer J; Teply I
    Biol Psychiatry; 1988 Dec; 24(8):925-36. PubMed ID: 3266076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosyl-L-methionine in the treatment of Alzheimer's disease.
    Cohen BM; Satlin A; Zubenko GS
    J Clin Psychopharmacol; 1988 Feb; 8(1):43-7. PubMed ID: 3350998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet membrane fluidity in Alzheimer's disease and multi-infarct dementia: a spin label study.
    Kaakkola S; Rosenberg PH; Alila A; Erkinjuntti T; Sulkava R; Palo J
    Acta Neurol Scand; 1991 Jul; 84(1):18-21. PubMed ID: 1656688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
    Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
    Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.
    van Rensburg SJ; Carstens ME; Potocnik FC; Aucamp AK; Taljaard JJ; Koch KR
    Neurochem Res; 1992 Aug; 17(8):825-9. PubMed ID: 1641066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.